go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Gilead Sciences Ltd
Flowers Building, Granta Park, Abington, Cambridge, Cambridgeshire, CB21 6GT, UK
Telephone: +44 (0)1223 897 300
Fax: +44 (0)1223 897 291
Medical Information Direct Line: +44 (0)1223 897 555
Medical Information e-mail: ukmedinfo@gilead.com
Customer Care direct line: +44 (0)1223 897 400
Medical Information Facsimile: +44 (0)1223 897 281
Patient Information Leaflet last updated on medicines.ie: 16/12/2011
PIL Atripla 600 mg/200 mg/245 mg film- coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 16/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to improve clarity and readability
Updated on 05/09/2011 and displayed until 16/12/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
Updated on 24/01/2011 and displayed until 05/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 07/12/2009 and displayed until 24/01/2011
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 24/04/2009 and displayed until 07/12/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 30/01/2009 and displayed until 24/04/2009
Reasons for adding or updating:
  • Change to drug interactions
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 11/09/2008 and displayed until 30/01/2009
Reasons for adding or updating:
  • Change to drug interactions
  • Introduction of new pack/pack size
Updated on 26/03/2008 and displayed until 11/09/2008
Reasons for adding or updating:
  • Change of manufacturer
  • Change to marketing authorisation holder
  • Change to further information section
Updated on 08/01/2008 and displayed until 26/03/2008
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Tenofovir disoproxil fumarate
  Efavirenz
  emtricitabine